Pseudomonas eradication treatment in Europe: Are there still differences between former East and West?

I. Weber (Rostock, Germany), M. Ballmann (Rostock, Germany)

Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Session: Infection and inflammation in cystic fibrosis
Session type: Thematic Poster
Number: 983
Disease area: Paediatric lung diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Weber (Rostock, Germany), M. Ballmann (Rostock, Germany). Pseudomonas eradication treatment in Europe: Are there still differences between former East and West?. 983

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The shorter multidrug-resistant tuberculosis treatment regimen in Singapore: are patients from South-East Asia eligible?
Source: Eur Respir J, 50 (2) 1700753; 10.1183/13993003.00753-2017
Year: 2017



Tuberculosis outbreak in East Greenland: groups at risk in an isolated arctic setting
Source: Eur Respir J 2015; 46: 865-869
Year: 2015


Multidrug-resistant tuberculosis in Eastern Europe: still on the increase?
Source: Eur Respir J 2012; 39: 1290-1291
Year: 2012


Prognosis and outcome in patients with extremely drug resistant tuberculosis from the Western Cape province, South Africa
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008

Prevalence and characteristic of drug-resistant tuberculosis patients in South Halmahera District, eastern Indonesia
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020


Introduction: The burden of tuberculosis drug resistance in Eastern Europe: the Moldavian experience
Source: Annual Congress 2010 - Multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2010

Drug resistance and HIV rates are high in Eastern European patients with Tuberculosis in a South East London Hospital
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019

Multidrug-resistant tuberculosis and HIV infection in Eastern Europe: Two overlapping epidemics
Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview
Year: 2012

Traditional healers, treatment delay, performance status and death from tuberculosis in rural South Africa
Source: Eur Respir J 2005; 26: Suppl. 49, 428s
Year: 2005

Gender differences in inequalities in asthma: the North West Adelaide health study
Source: Annual Congress 2006 - Highlights of asthma epidemiology
Year: 2006


The confronting COPD survey in Central and Eastern Europe
Source: Eur Respir J 2005; 26: Suppl. 49, 296s
Year: 2005

Is Europe ready to reach tuberculosis elimination? An outbreak report from Southern Italy
Source: Eur Respir J 2015; 46: 274-277
Year: 2015


Tuberculosis control in Siberia and Far East for extrapulmonary forms
Source: Annual Congress 2010 - Global tuberculosis control
Year: 2010

Tuberculosis control in Siberia and Far East for extrapulmonary forms
Source: Eur Respir J 2007; 30: Suppl. 51, 423s
Year: 2007

Tuberculosis control in Siberia and Far East for extrapulmonary forms
Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis
Year: 2008


TB program for refugees in Russian North Caucasus
Source: Eur Respir J 2002; 20: Suppl. 38, 163s
Year: 2002

Death rates in patients during and after MDR-TB treatment in a semi rural area of South Africa
Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis
Year: 2011